The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

References

• MurrayCJLopezADMortality by cause of death for eight regions of the world. Global Burden of Disease StudyLancet1997349 9061126912769142060
   PubMed Web of Science ®Google Scholar
• Writing Group MemberLloyd-JonesDAdamsRJBrownTMHeart disease and stroke statistics – 2010 update: a report from the American Heart AssociationCirculation20101217e46e21520019324
   PubMed Web of Science ®Google Scholar
• BroderickJBrottTKothariRThe Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacksStroke19982924154219472883
   PubMed Web of Science ®Google Scholar
• KellyJRuddALewisRHuntBJVenous thromboembolism after acute strokeStroke200132126226711136946
   PubMed Web of Science ®Google Scholar
• AlbersGWAmarencoPEastonJDSaccoRLTealPAmerican College of Chest PhysiciansAntithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition)Chest2008133 6 Suppl630S669S18574275
   PubMed Web of Science ®Google Scholar
• ShermanDGAlbersGWBladinCThe efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonLancet2007369 95701347135517448820
   PubMed Web of Science ®Google Scholar
• PineoGLinJSternLSubrahmanianTAnnemansLEconomic impact of enoxaparin after acute ischemic stroke based on PREVAILClin Appl Thromb Hemost201117215015721159705
   PubMed Web of Science ®Google Scholar
• PineoGLinJSternLSubrahmanianTAnnemansLEconomic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trialJ Hosp Med20127317618222058011
   PubMed Web of Science ®Google Scholar
• TongXKuklinaEVGillespieCGeorgeMGMedical complications among hospitalizations for ischemic stroke in the United States from 1998 to 2007Stroke201041598098620203317
   PubMed Web of Science ®Google Scholar
• McCarthySTTurnerJLow-dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary emboli following acute strokeAge Ageing198615284883962762
   PubMed Web of Science ®Google Scholar
• TurpieAGProphylaxis of venous thromboembolism in stroke patientsSemin Thromb Hemost19972321551579200340
   PubMed Web of Science ®Google Scholar
• HarveyRLLovellLLBelangerNRothEJThe effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort studyArch Phys Med Rehabil20048571070107515241752
   PubMed Web of Science ®Google Scholar
• GeertsWHBergqvistDPineoGFPrevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl381S453S18574271
   PubMed Web of Science ®Google Scholar
• HillbomMEriläTSotaniemiKTatlisumakTSarnaSKasteMEnoxaparin versus heparin for prevention of deep vein thrombosis in acute ischaemic stroke: a randomized, double-blind studyActa Neurol Scand20021062849212100367
   PubMed Web of Science ®Google Scholar
• AdamsHPJrdel ZoppoGAlbertsMJGuidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologistsCirculation200711520e478e53417515473
   PubMed Web of Science ®Google Scholar
• QaseemAChouRHumphreyLLStarkeyMShekellePfor the Clinical Guidelines Committee of the American College of PhysiciansVenous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of PhysiciansAnn Intern Med2011155962563222041951
   PubMed Web of Science ®Google Scholar
• SandercockPAvan den BeltAGLindleyRISlatteryJAntithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trialsJ Neurol Neurosurg Psychiatry199356117258429318
   PubMed Web of Science ®Google Scholar
• International Stroke Trial Collaborative GroupThe International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic strokeLancet19973499065156915819174558
   PubMed Web of Science ®Google Scholar
• BathPMIddendenRBathFJLow-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trialsStroke20003171770177810884486
   PubMed Web of Science ®Google Scholar
• SandercockPACounsellCTsengMCLow-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokeCochrane Database Syst Rev20083CD00011918646059
   PubMed Web of Science ®Google Scholar
• DienerHCRingelsteinEBvon KummerRProphylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular- weight heparin certoparin: results of the PROTECT TrialStroke200637113914416306456
   PubMed Web of Science ®Google Scholar
• PetrauskieneVFalkMWaernbaumINorbergMErikssonJWThe risk of venous thromboembolism is markedly elevated in patients with diabetesDiabetologia20054851017102115778859
   PubMed Web of Science ®Google Scholar
• KaseCSAlbersGWBladinCNeurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) studyStroke200940113532354019696423
   PubMed Web of Science ®Google Scholar
• CohenATDavidsonBLGallusASEfficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ2006332753732532916439370
   PubMed Web of Science ®Google Scholar
• CohenATSpiroTEBullerHRRivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: Magellan sub-group analyses. Abstract 0-MO-034Proceedings of the 23rd Congress of the International Society on Thrombosis HaemostasisJuly 23–28, 2011Kyoto, Japan
   Google Scholar
• MahaffeyKStroke prevention using the oral direct factor Xa inhibitor rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation (ROCKET AF)Proceedings of the American Heart Association 2010 Scientific SessionsNovember 15, 2010Chicago, IL
   Google Scholar
• GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• WallentinLYusufSEzekowitzMDEfficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLancet2010376974597598320801496
   PubMed Web of Science ®Google Scholar
• SpriggNGrayLJBathPMCompression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischemic Stroke TrialJ Stroke Cerebrovasc Dis200514520320917904027
   PubMedGoogle Scholar
• CLOTS Trials CollaborationDennisMSandercockPAEffectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trialLancet200937396791958196519477503
   PubMed Web of Science ®Google Scholar
• CLOTS (Clots in Legs Or sTockings after Stroke) Trial CollaborationThigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trialAnn Intern Med2010153955356220855784
   PubMed Web of Science ®Google Scholar
• McGarryLJThompsonDWeinsteinMCGoldhaberSZCost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatientsAm J Manag Care200410963264215515996
   PubMed Web of Science ®Google Scholar
• DeitelzweigSBBeckerRLinJBennerJComparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolismThromb Haemost2008100581082018989525
   PubMed Web of Science ®Google Scholar
• BurleighEWangCFosterDThromboprophylaxis in medically ill patients at risk for venous thromboembolismAm J Health Syst Pharm20066320 Suppl 6S23S2917032931
   PubMed Web of Science ®Google Scholar
• The Joint CommissionVenous thromboembolism core measure set Available from: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htmAccessed November 18, 2011
   Google Scholar
• US Department of Health and Human Services, Centers for Medicare and Medicaid ServicesHospital-acquired conditions Available from: http://www.cms.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp#TopOfPageAccessed November 18, 2011
   Google Scholar
• PineoGFHullRDEconomic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patientsClin Appl Thromb Hemost200915548950019520676
   PubMed Web of Science ®Google Scholar